ARNICAID

Manufacturer: Hyland's Inc.
Effective date: 2022-11-28
Label type: HUMAN OTC DRUG LABEL
Version: 8
Source: legacy-cache
Hydrated at: 2026-08-01 21:46:17

Label at a glance#

ProductARNICAID

Active ingredientARNICA MONTANA, HYPERICUM PERFORATUM, RUTA GRAVEOLENS FLOWERING TOP, LEDUM PALUSTRE TWIG, BELLIS PERENNIS

Label structure9 sections

Indications and uses

Temporarily relieves symptoms of: ■ pain ■ bruising ■ muscle soreness or swelling due to minor injuries from falls, strains or sprains

Dosage and administration

■ Use as directed. Adults and children 12 years and over At onset of symptoms, dissolve 2–3 tablets under tongue every 4 hours as needed. If the initial dosage is not providing immediate relief, dissolve 2–3 tablets under tongue every 15 minutes until relieved, up to 6 doses. Children 6 years to under 12 years At onset of symptoms, dissolve 1–2 tablets under tongue every 4 hours as needed. If the initial dosage is...

Contacts and useful links#

PhoneLabel contact(800) 624-9659

Websitewww.hylands.com

www.hylands.com

Label contents#

Full prescribing information#

Drug Facts

SPL UNCLASSIFIED SECTION

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

*Active Ingredients*	*Purpose*
Arnica Montana 30X HPUS	bruising, swelling, muscle soreness and pain
Bellis Perennis 6X HPUS	swelling and sore muscles
Hypericum Perforatum 6X HPUS	shooting and radiating pains
Ledum Palustre 6X HPUS	pain
Ruta Graveolens 6X HPUS	pain

“HPUS” indicates that the active ingredients are in the official Homeopathic Pharmacopœia of the United States.

Uses

INDICATIONS & USAGE SECTION

Temporarily relieves symptoms of: ■ pain ■ bruising ■ muscle soreness or swelling due to minor injuries from falls, strains or sprains

Warnings

WARNINGS SECTION

Stop use and ask a doctor if

OTC - STOP USE SECTION

symptoms persist for more than 7 days or worsen.

If pregnant or breastfeeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Directions

DOSAGE & ADMINISTRATION SECTION

■ Use as directed.

Adults and children 12 years and over	At onset of symptoms, dissolve 2–3 tablets under tongue every 4 hours as needed. If the initial dosage is not providing immediate relief, dissolve 2–3 tablets under tongue every 15 minutes until relieved, up to 6 doses.
Children 6 years to under 12 years	At onset of symptoms, dissolve 1–2 tablets under tongue every 4 hours as needed. If the initial dosage is not providing immediate relief, dissolve 1 tablet under tongue every 15 minutes until relieved, up to 6 doses.

Inactive Ingredient

INACTIVE INGREDIENT SECTION

Acacia Gum,Lactose

Questions?

SPL UNCLASSIFIED SECTION

www.hylands.com or (800) 624-9659

Indications and Usage

RECENT MAJOR CHANGES SECTION

Uses

 Temporarily relieves the symptoms of:

 pain  bruising

 muscle soreness or swelling due to minor injuries from falls, strains or sprains

Dosage and Administration

RECENT MAJOR CHANGES SECTION

Directions

Adults and children 12 years and over

Dissolve 2–3 tablets under tongue every 4 hours. If the initial dosage is not providing relief, dissolve 2–3 tablets under tongue every 15 minutes, up to 6 doses.

Children 6 years

to under 12 years

Dissolve 1–2 tablets under tongue every 4 hours. If the initial

dosage is not providing relief, dissolve 1 tablet under tongue

every 15 minutes, up to 6 doses.

PRINCIPAL DISPLAY PANEL - 50 TABLET BOTTLE CARTON

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Hyland's

NATURALS

ARNICAID

PAIN RELIEF*

MINOR INJURIES

BRUISING & SWELLING

50 QUICK-DISSOLVING

TABLETS

HOMEOPATHIC

Carton

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ARNICA MONTANA	ACTIVE INGREDIENT	O80TY208ZW	1
BELLIS PERENNIS	ACTIVE INGREDIENT	2HU33I03UY	1
HYPERICUM PERFORATUM	ACTIVE INGREDIENT	XK4IUX8MNB	1
LEDUM PALUSTRE TWIG	ACTIVE INGREDIENT	877L01IZ0P	1
RUTA GRAVEOLENS FLOWERING TOP	ACTIVE INGREDIENT	N94C2U587S	1
ARNICA MONTANA	ACTIVE MOIETY	O80TY208ZW	1
BELLIS PERENNIS	ACTIVE MOIETY	2HU33I03UY	1
HYPERICUM PERFORATUM	ACTIVE MOIETY	XK4IUX8MNB	1
LEDUM PALUSTRE TWIG	ACTIVE MOIETY	877L01IZ0P	1
RUTA GRAVEOLENS FLOWERING TOP	ACTIVE MOIETY	N94C2U587S	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

ARNICAID
arnica montana, hypericum perforatum, ruta graveolens flowering top, ledum palustre twig, and bellis perennis
LACTOSE
ACACIA
ARNICA MONTANA
HYPERICUM PERFORATUM
RUTA GRAVEOLENS FLOWERING TOP
LEDUM PALUSTRE TWIG
BELLIS PERENNIS

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
54973-0229	54973-0229-1, 54973-0229-2, 54973-0229-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
LACTOSE	J2B2A4N98G	IACT
ACACIA	5C5403N26O	IACT
ARNICA MONTANA	O80TY208ZW	ACTIB
HYPERICUM PERFORATUM	XK4IUX8MNB	ACTIB
RUTA GRAVEOLENS FLOWERING TOP	N94C2U587S	ACTIB
LEDUM PALUSTRE TWIG	877L01IZ0P	ACTIB
BELLIS PERENNIS	2HU33I03UY	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 36 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / BUCCAL	296.7 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / ORAL	1682 mg/15ml		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, DELAYED RELEASE / ORAL	231.84 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY	193.8 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	FILM, EXTENDED RELEASE / TRANSDERMAL	675 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / RECTAL	8 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED PELLETS / ORAL	135.2 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAMUSCULAR	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, COATED / ORAL	332.05 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, DELAYED RELEASE / ORAL		160 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / RECTAL	20 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CREAM / VAGINAL	3 %w/w		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / RESPIRATORY (INHALATION)	90 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / RESPIRATORY (INHALATION)	44.4 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAVENOUS	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / VAGINAL	430 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		620 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, SOLUTION / INTRAVENOUS	0.45 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CONCENTRATE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / ORAL	530 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	GRANULE, FOR SUSPENSION / ORAL	512.5 mg/5ml		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EFFERVESCENT / ORAL	96.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EXTENDED RELEASE / ORAL	400 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / SUBLINGUAL		352 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED / ORAL	590 mg		Exact identifier — unii candidate 36 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
051c7bdf-9907-b9da-e063-6394a90aaee1			4fe8ec3f-af57-46d0-9e2c-b17caa572ff0	2023-09-11	Warnings	Exact identifier spl set id: 4fe8ec3f-af57-46d0-9e2c-b17caa572ff0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.